Home
World Journal of Biology Pharmacy and Health Sciences
ISSN Approved | International, Peer reviewed, Referred, Open access Journal

Main navigation

  • Home
    • Journal Information
    • Abstracting and Indexing
    • Editorial Board Members
    • Reviewer Panel
    • Journal Policies
    • WJBPHS CrossMark Policy
    • Publication Ethics
    • Current Issue
    • Issue in Progress
    • Past Issues
    • Instructions for Authors
    • Article processing fee
    • Track Manuscript Status
    • Get Publication Certificate
    • Become a Reviewer panel member
    • Join as Editorial Board Member
  • Contact us
  • Downloads

ISSN Approved Journal | | IMPACT FACTOR 8.16 | | eISSN: 2582-5542 | |  Free Crossref DOI 

Fast Publication within 2 days | | Low Article Processing Charges | | Peer Reviewed and Referred Journal

Research and review articles are invited for publication in September 2026 (Volume 27, Issue 3) Submit Paper

Gestational syphilis in Brazil between 2008 and 2022: Ethnic disparities and clinical-stage trends

Breadcrumb

  • Home
  • Gestational syphilis in Brazil between 2008 and 2022: Ethnic disparities and clinical-stage trends

Louise Pereira de Moraes Vieira *, Hayana Lara Assunção Muniz, Natália Menezes Marques, Raquel Gabrielli Oliveira Costaa, Thaynara Ramos Maciel, ⁠Iolanda Ferreira Viana, Jessica Vitoria Argolo De Carvalho, Karina de Jesus do Nascimento, Moana Augusta Costa Santos, Giselle Alves Silva and Raiana Bogéa Anchieta 

Institute of Medical Education, Alagoinhas, Brazil.

Research Article

World Journal of Biology Pharmacy and Health Sciences, 2025, 21(02), 410-418

Article DOI: 10.30574/wjbphs.2025.21.2.0159

DOI url: https://doi.org/10.30574/wjbphs.2025.21.2.0159

Received on 28 December 2024; revised on 15 February 2025; accepted on 18 February 2025

This study investigated gestational syphilis trends in Brazil from 2008 to 2022, focusing on ethnic disparities, temporal progression, and clinical-stage distribution. Using retrospective data from Brazil’s Notifiable Diseases Information System (SINAN), we analyzed 410,630 reported cases to quantify annual trends and interactions between ethnicity, time, and disease severity. A Negative Binomial regression model revealed a 35% annual increase in cases (Incidence Rate Ratio [IRR] = 1.35, 95% CI: 1.20–1.53), with the highest burden observed among the Brown (Parda) population (53.5% of cases). Latent-stage infections predominated (44.2%), followed by primary (37.1%), tertiary (12.1%), and secondary stages (6.6%). Indigenous populations exhibited marginally slower progression (IRR = 0.86, p= 0.090), while no significant differences emerged between Black (Preta) and other ethnic groups. Structural inequities, including delayed diagnosis and inconsistent prenatal care, were linked to persistent latent-stage infections and elevated tertiary-stage rates in marginalized communities. These findings underscore the urgent need for equity-focused interventions, such as expanded rapid testing and culturally tailored healthcare programs, to mitigate Brazil’s escalating syphilis epidemic. 

Gestational Syphilis; Ethnic Disparities; Latent Stage; Prenatal Care; Public Health

https://wjbphs.com/sites/default/files/fulltext_pdf/WJBPHS-2025-0159.pdf

Preview Article PDF

Louise Pereira de Moraes Vieira, Hayana Lara Assunção Muniz, Natália Menezes Marques, Raquel Gabrielli Oliveira Costaa, Thaynara Ramos Maciel, Iolanda Ferreira Viana, Jessica Vitoria Argolo De Carvalho, Karina de Jesus do Nascimento, Moana Augusta Costa Santos, Giselle Alves Silva and Raiana Bogéa Anchieta. Gestational syphilis in Brazil between 2008 and 2022: Ethnic disparities and clinical-stage trends . World Journal of Biology Pharmacy and Health Sciences, 2025, 21(02), 410-418. Article DOI: https://doi.org/10.30574/wjbphs.2025.21.2.0159.

Get Certificates

Get Publication Certificate

Download LoA

Check Corssref DOI details

Issue details

Issue Cover Page

Editorial Board

Table of content


Copyright © Author(s). All rights reserved. This article is published under the terms of the Creative Commons Attribution 4.0 International License (CC BY 4.0), which permits use, sharing, adaptation, distribution, and reproduction in any medium or format, as long as appropriate credit is given to the original author(s) and source, a link to the license is provided, and any changes made are indicated.


Copyright © 2026 World Journal of Biology Pharmacy and Health Sciences (WJBPHS) - All rights reserved

Developed & Designed by VS Infosolution